These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23092552)

  • 1. A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis.
    Qi J; Kan F; Ye X; Guo M; Zhang Y; Ren G; Li D
    Int Immunopharmacol; 2012 Dec; 14(4):770-8. PubMed ID: 23092552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model.
    Li Q; Ren G; Xu L; Wang Q; Qi J; Wang W; Zhou B; Han X; Sun C; Wu Q; Yu Y; Peng Z; Zheng S; Li D
    Int Immunopharmacol; 2014 Jul; 21(1):119-27. PubMed ID: 24800661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis.
    Qi J; Ye X; Ren G; Kan F; Zhang Y; Guo M; Zhang Z; Li D
    Mol Immunol; 2014 Feb; 57(2):59-65. PubMed ID: 24091292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis.
    Wang Y; Wu Q; Liu Z; Guo X; Zhou L; Wang Y; Song L; Wang N; Zheng Q; Wang W; Ren G; Li D
    Biomed Pharmacother; 2017 May; 89():426-437. PubMed ID: 28249243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
    Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
    Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
    Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
    Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic efficacy of three bispecific antibodies on rheumatoid arthritis mice models].
    Li QC; Han XH; Zhou B; Wang WF; Ren GP; Sun CY; Wu Q; Yu YH; Xu LM; Wang QY; Qi JY; Wei YQ; Cao HW; Han JY; Li DS
    Yao Xue Xue Bao; 2014 Mar; 49(3):322-8. PubMed ID: 24961102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.
    Lee JH; Cho ML; Kim JI; Moon YM; Oh HJ; Kim GT; Ryu S; Baek SH; Lee SH; Kim HY; Kim SI
    J Rheumatol; 2009 Apr; 36(4):684-92. PubMed ID: 19228664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance.
    Lu Y; Xiao J; Wu ZW; Wang ZM; Hu J; Fu HZ; Chen YY; Qian RQ
    Phytomedicine; 2012 Jul; 19(10):882-9. PubMed ID: 22673798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
    Magari K; Miyata S; Ohkubo Y; Mutoh S
    Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis.
    Takagi N; Mihara M; Moriya Y; Nishimoto N; Yoshizaki K; Kishimoto T; Takeda Y; Ohsugi Y
    Arthritis Rheum; 1998 Dec; 41(12):2117-21. PubMed ID: 9870868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
    Moon DO; Kim MO; Choi YH; Park YM; Kim GY
    Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
    Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
    Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.